Stay updated on Pembrolizumab for Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    7 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change represents an update in the study record of a clinical trial involving pembrolizumab in patients with hepatitis B virus-related hepatocellular carcinoma, focusing on the efficacy and safety of the treatment and the serial change in RNA expression of immune-related gene panel in post-treatment biopsy tissue.
    Difference
    0.1%
    Check dated 2024-06-06T14:31:51.000Z thumbnail image
  7. Check
    21 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying the health conditions and prior treatments required for participants. Previously, no information was provided about the participation criteria for collaborators and investigators.
    Difference
    52%
    Check dated 2024-05-22T21:01:18.000Z thumbnail image
  8. Check
    43 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2024-04-30T22:39:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Hepatocellular Carcinoma Clinical Trial page.